AGIO - AGIOS PHARMACEUTICALS, INC.

QQQ $ 480.77 $ -0.53 (-0.11 %)

DIA $ 408.29 $ -0.60 (-0.15 %)

SPY $ 558.71 $ -0.45 (-0.08 %)

TLT $ 98.65 $ 0.76 (0.78 %)

GLD $ 232.32 $ -1.40 (-0.6 %)

Previous Close

$ 45.47

Open

$ 45.43

Bid

$ 44.94 x 100

Ask

-- x --

Day's Range

$ 44.78 - $ 45.64

52 Week Range

$ 19.80 - $ 50.35

Volume

361,803

Average Volume

Market Cap

2.58B

Beta (5Y Monthly)

$ 0.89

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-01-2024	06-30-2024	10-Q
2	05-02-2024	03-31-2024	10-Q
3	02-15-2024	12-31-2023	10-K
4	11-02-2023	09-30-2023	10-Q
5	08-03-2023	06-30-2023	10-Q
6	05-04-2023	03-31-2023	10-Q
7	02-23-2023	12-31-2022	10-K
8	11-03-2022	09-30-2022	10-Q
9	08-04-2022	06-30-2022	10-Q
10	05-05-2022	03-31-2022	10-Q
11	02-24-2022	12-31-2021	10-K
12	11-03-2021	09-30-2021	10-Q
13	07-29-2021	06-30-2021	10-Q
14	04-29-2021	03-31-2021	10-Q
15	02-25-2021	12-31-2020	10-K
16	11-05-2020	09-30-2020	10-Q
17	07-30-2020	06-30-2020	10-Q
18	04-30-2020	03-31-2020	10-Q
19	02-19-2020	12-31-2019	10-K
20	10-31-2019	09-30-2019	10-Q
21	08-01-2019	06-30-2019	10-Q
22	05-02-2019	03-31-2019	10-Q
23	02-14-2019	12-31-2018	10-K
24	11-01-2018	09-30-2018	10-Q
25	08-02-2018	06-30-2018	10-Q
26	05-04-2018	03-31-2018	10-Q
27	02-14-2018	12-31-2017	10-K
28	11-01-2017	09-30-2017	10-Q
29	08-08-2017	06-30-2017	10-Q
30	05-04-2017	03-31-2017	10-Q
31	02-16-2017	12-31-2016	10-K
32	11-03-2016	09-30-2016	10-Q
33	08-08-2016	06-30-2016	10-Q
34	05-09-2016	03-31-2016	10-Q
35	02-26-2016	12-31-2015	10-K
36	11-06-2015	09-30-2015	10-Q
37	08-07-2015	06-30-2015	10-Q
38	05-11-2015	03-31-2015	10-Q
39	02-24-2015	12-31-2014	10-K
40	11-07-2014	09-30-2014	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Agios Pharmaceuticals shares are trading h...
08/07/2024 12:52:39

Agios To Receive $1.1B Milestone Payments ...
08/06/2024 21:51:52

– Agios Expects to Receive $905 Million Payment from Royalty Pharma and $200 Million Payment from Servier in Q3 2024; Payments ...

RBC Capital Maintains Outperform on Agios ...
08/02/2024 19:37:40

RBC Capital analyst Gregory Renza maintains Agios Pharmaceuticals (NASDAQ:AGIO) with a Outperform and raises the price targe...

agios-pharmaceuticals-rare-blood-disorder-drug-misses-primary-goal-in-pediatric-study-stock-slides

Agios Pharmaceuticals' Rare Blood Disorder...
08/01/2024 17:42:10

Agios Pharmaceuticals' Phase 3 ACTIVATE-KidsT study results reveal that mitapivat achieved a 28.1% transfusion reduction in...

Agios Pharmaceuticals Q2 2024 GAAP EPS $(1...
08/01/2024 10:35:48

Agios Pharmaceuticals (NASDAQ:AGIO) reported quarterly losses of $(1.69) per share which missed the analyst consensus estimate ...

Agios Announces Results From Phase 3 ACTIV...
08/01/2024 10:34:05

Expert Ratings For Agios Pharmaceuticals
06/17/2024 14:01:38

Cantor Fitzgerald Reiterates Overweight on...
06/17/2024 13:31:59

Cantor Fitzgerald analyst Eric Schmidt reiterates Agios Pharmaceuticals (NASDAQ:AGIO) with a Overweight.

Agios Announced Earlier Results From Its ...
06/15/2024 16:38:25

Agios Pharmaceuticals, Inc. (NASDAQ:AGIO), a leader in cellular metabolism and pyruvate kinase (PK) activation pioneering thera...

Agio Pharmaceuticals Announces Poster Titl...
06/14/2024 12:40:45

https://docs.publicnow.com/viewDoc?hash_primary=94808CEEFD31376A3A6A2796DEEF8050584F174C

JP Morgan Reinstates Neutral on Agios Phar...
06/13/2024 21:07:28

JP Morgan analyst Tessa Romero reinstates Agios Pharmaceuticals (NASDAQ:AGIO) with a Neutral and announces $46 price target.

10-health-care-stocks-whale-activity-in-todays-session

10 Health Care Stocks Whale Activity In To...
06/13/2024 17:35:22

novavax-and-agios-pharmaceuticals-were-among-the-10-biggest-mid-cap-gainers-last-week-june-1-june-7-are-these-in-your-portfolio

Novavax And Agios Pharmaceuticals Were Amo...
06/09/2024 18:29:27

Mid-cap stocks saw significant gains last week, with top performers like AGIO, VRNT, and NVAX, causing analysts to raise their ...

Goldman Sachs Maintains Neutral on Agios P...
06/04/2024 15:16:38

Goldman Sachs analyst Salveen Richter maintains Agios Pharmaceuticals (NASDAQ:AGIO) with a Neutral and raises the price targ...

RBC Capital Maintains Outperform on Agios ...
06/04/2024 13:32:11

RBC Capital analyst Gregory Renza maintains Agios Pharmaceuticals (NASDAQ:AGIO) with a Outperform and raises the price targe...

why-is-agios-pharmaceuticals-stock-trading-higher-on-monday

Why Is Agios Pharmaceuticals Stock Trading...
06/03/2024 16:11:50

Agios Pharmaceuticals shares rose after it announced its Phase 3 ENERGIZE-T study of mitapivat in adults with transfusion-depen...

stericycle-marinemax-agios-pharmaceuticals-and-other-big-stocks-moving-higher-on-monday

Stericycle, MarineMax, Agios Pharmaceutica...
06/03/2024 14:39:44

Agios Pharmaceuticals Reports Phase 3 Resu...
06/03/2024 10:32:51

Agios Pharmaceuticals, Inc. (NASDAQ:AGIO), a leader in cellular metabolism and pyruvate kinase (PK) activation pioneering thera...

why-applied-dna-sciences-shares-are-trading-lower-by-around-68-here-are-other-stocks-moving-in-tuesdays-mid-day-session

Why Applied DNA Sciences Shares Are Tradin...
05/28/2024 17:24:16

why-is-agios-pharmaceuticals-stock-trading-higher-on-tuesday

Why Is Agios Pharmaceuticals Stock Trading...
05/28/2024 17:00:41

Agios Pharmaceuticals sells its 15% royalty rights on U.S. net sales of Servier's vorasidenib to Royalty Pharma for $905 mi...